The Complete Guide to GLP-1 Medications for Teens & Young Adults

Everything you need to know about GLP-1 receptor agonists for adolescent and young adult weight management. Grounded in clinical evidence.

Written by the Thryvwell Care Team · Medically reviewed by Dr. Glenda Pettaway, MD, MS, FAAP · Updated July 2026 · 12 min read

A Thryvwell care package with medication and welcome materials arranged on a kitchen counter

In this guide

What are GLP-1 medications?

GLP-1 medications are a class of drugs that mimic a natural hormone the body already produces called glucagon-like peptide-1. This hormone plays a key role in telling the brain "I'm full," slowing down how fast food leaves the stomach, and helping regulate blood sugar.

Originally developed for type 2 diabetes, researchers discovered these medications also help with significant, sustained weight loss. For teens and young adults with obesity, they represent a clinically proven tool that works alongside healthy lifestyle changes.

It is important to understand that these medications are not a cure for obesity on their own. They work best as part of a comprehensive approach that includes healthy eating habits, regular physical activity, restful sleep, behavioral support, and long-term lifestyle changes.

Which medications are approved for adolescents?

Two GLP-1 medications are currently FDA-approved for adolescents aged 12 and older. The American Academy of Pediatrics recommends considering these medications as part of comprehensive treatment, particularly when obesity is accompanied by related medical conditions.

Wegovy® (semaglutide)

Once weekly

A once-weekly injection approved for adolescents aged 12+ with obesity. Supported by the STEP TEENS clinical trial, which demonstrated an average 16% reduction in BMI over 68 weeks.

Saxenda® (liraglutide)

Daily

A daily injection approved for adolescents aged 12+ with obesity. Clinical studies showed approximately 5% BMI reduction over 56 weeks when combined with lifestyle changes.

Zepbound® (tirzepatide)

Not yet approved for under 18

A once-weekly dual GIP/GLP-1 receptor agonist. While showing promise in adult studies, it is not yet FDA-approved for patients under 18. Pediatric trials are ongoing.

A note on compounded medications

At Thryvwell, we only prescribe FDA-approved, brand-name GLP-1 medications. We never use compounded versions, which lack the rigorous safety testing, quality controls, and clinical trial data that FDA-approved drugs undergo. Patient safety is non-negotiable.

How do they work?

GLP-1 medications work through multiple pathways: regulating appetite in the brain, slowing gastric emptying, stabilizing blood sugar, and reducing fat accumulation in the liver. Clinical studies show adolescents can achieve 5–16% BMI reduction when combined with lifestyle changes.

One medication, four body systems

Brain

Quiets appetite signals so fullness registers sooner

Stomach

Slows emptying so meals keep you satisfied longer

Pancreas

Steadies blood sugar by improving insulin response

Liver

Reduces fat buildup, protecting long-term liver health

How GLP-1 medications work across four key body systems

Read the full breakdown

How GLP-1 medications work across four key body systems.

Are they safe for teenagers?

These medications have been studied specifically in adolescent populations and are generally safe when prescribed and monitored by qualified clinicians. Common side effects (nausea, stomach discomfort) are usually mild and improve with gradual dose titration.

Read the full safety profile

Clinical evidence, known side effects, monitoring protocols, and what long-term data shows.

Why supervised care matters

A prescription alone isn't treatment. Research shows that combining GLP-1 medication with a structured weight management program is significantly more effective than medication alone because it addresses both the biological and behavioral aspects of weight management. Adolescent bodies are still developing, and without proper clinical oversight, treatment can lead to muscle loss, weight regain, and pronounced side effects.

A comprehensive program includes:

Three teenagers playing basketball outdoors in warm evening light
  • Medical supervision: Regular follow-up to monitor weight, blood pressure, blood sugar (if applicable), medication response, and side effects.
  • Personalized nutrition counseling: A qualified healthcare professional helps create an eating plan that emphasizes adequate protein, fiber, hydration, and sustainable calorie reduction.
  • Physical activity plan: A gradual exercise program that combines aerobic activity with strength training to help preserve muscle mass during weight loss.
  • Behavioral support: Counseling and cognitive behavioral strategies to build healthy habits, improve sleep, manage stress, and address emotional eating.
  • Ongoing monitoring: Regular check-ins, food and activity tracking, and progress reviews to help maintain motivation and identify barriers early.

Maintaining healthy eating habits and regular physical activity is also important if medication is stopped, as weight regain is common without continued lifestyle support.

See the data

Why supervised care matters: with vs. without support, by the numbers.

What about nutrition?

Because GLP-1 medications reduce appetite, ensuring adequate nutrition requires active attention. Protein intake, hydration, and regular meals become more important, not less, during treatment.

A family sharing a fresh, balanced meal together at their dining table

Read the nutrition guide

How to maintain proper nutrition while on GLP-1 medication.

What if we want to stop the medication?

Weight regain can occur when GLP-1 medications are discontinued, which is why a thoughtful transition plan (gradual dose reduction, intensified lifestyle support, and more frequent check-ins) is essential.

Read about discontinuation

Evidence on stopping GLP-1, weight maintenance strategies, and long-term planning.

Questions to ask your provider

Whether you are considering Thryvwell or exploring other options, here are questions to ask your healthcare provider:

  1. 1.Am I (or is my teen) a good candidate for GLP-1 medication?
  2. 2.Which medication do you recommend, and why?
  3. 3.What side effects should we watch for, and when should we call?
  4. 4.How will growth, nutrition, and development be monitored during treatment?
  5. 5.Does my insurance cover this medication, and what are the out-of-pocket costs?
  6. 6.What lifestyle changes need to happen alongside the medication?
  7. 7.How long would treatment last, and what does the off-ramp look like?
  8. 8.What support is available during this process?

Who is eligible for GLP-1 medication?

FDA criteria, BMI thresholds, age requirements, and clinical guidelines, in plain language.

A note on obesity as a medical condition

Obesity is recognized by the American Medical Association, the American Academy of Pediatrics, and the World Health Organization as a chronic disease that often begins in childhood. It is influenced by genetics, environment, hormones, and many factors beyond personal willpower.

"Treatment should be about improving health and quality of life. A person's worth has nothing to do with their weight."

, Thryvwell Care Philosophy

At Thryvwell, we approach every patient with compassion, free from judgment or stigma. With proper GLP-1 treatment, alongside lifestyle changes and behavioral support, teens and young adults can achieve meaningful improvements in their health, confidence, and long-term wellbeing.

Ready to Thrive?

See if you qualify. Our eligibility screener takes less than 2 minutes. No commitment required.

Patient Resources

All teen resources

Explore these resources designed to build understanding, reduce stigma, and support your journey.

The information on this page is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any treatment. Individual results may vary.

Thryvwell Health

Safe, comprehensive weight care for teens and young adults ages 12–26. We provide specialized clinical oversight, personalized health insights, and educational content to build lasting health habits. Available in all 50 states.

Stay updated on Thryvwell Health

Enter your email for news and early access. No spam, ever.

¹ CDC NHANES 2017–2020 | ² AAP Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity, 2023. *Individual results may vary. Statistics reflect clinical trial outcomes (Weghuber et al., NEJM 2022) in adolescents ages 12–17 receiving semaglutide 2.4 mg plus lifestyle intervention over 68 weeks. Treatment requires a prescription and medical supervision. The information on this website is for educational purposes only and does not constitute medical advice. GLP-1 medications are prescription-only and are prescribed based on individual clinical eligibility.

© 2026 Thryvwell Health, LLC. All rights reserved. All content, images, and materials are proprietary.

HIPAA CompliantFDA-Approved Medications OnlyAligned with Medicaid Quality Metrics

See if your family qualifies

Get Started